期刊论文详细信息
BMC Medicine
Obesity survival paradox in pneumonia: a meta-analysis
Qingyu Xiu1  Bing Li1  Keum Ji Jung2  Sun Ha Jee2  Yi Zhang3  Wei Nie1 
[1] Department of Respiratory Medicine, Shanghai Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China;Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Seoul 120-749, Korea;Department of Clinical Nutrition, The 452nd Hospital of PLA, Chengdu 610000, Sichuan, China
关键词: Meta-analysis;    Dose–response relationship;    Pneumonia;    Obesity;    Body mass index;   
Others  :  854918
DOI  :  10.1186/1741-7015-12-61
 received in 2013-11-26, accepted in 2014-03-13,  发布年份 2014
PDF
【 摘 要 】

Background

It is unclear whether an ‘obesity survival paradox’ exists for pneumonia. Therefore, we conducted a meta-analysis to assess the associations between increased body mass index (BMI), pneumonia risk, and mortality risk.

Methods

Cohort studies were identified from the PubMed and Embase databases. Summary relative risks (RRs) with their corresponding 95% confidence intervals (CIs) were calculated using a random effects model.

Results

Thirteen cohort studies on pneumonia risk (n = 1,536,623), and ten cohort studies on mortality (n = 1,375,482) were included. Overweight and obese individuals were significantly associated with an increased risk of pneumonia (RR = 1.33, 95% CI 1.04 to 1.71, P = 0.02, I2 = 87%). In the dose–response analysis, the estimated summary RR of pneumonia per 5 kg/m2 increase in BMI was 1.04 (95% CI 1.01 to 1.07, P = 0.01, I2 = 84%). Inversely, overweight and obese subjects were significantly associated with reduced risk of pneumonia mortality (RR = 0.83, 95% CI 0.77 to 0.91, P < 0.01, I2 = 34%). The estimated summary RR of mortality per 5 kg/m2 increase in BMI was 0.95 (95% CI 0.93 to 0.98, P < 0.01, I2 = 77%).

Conclusions

This meta-analysis suggests that an ‘obesity survival paradox’ exists for pneumonia. Because this meta-analysis is based on observational studies, more studies are required to confirm the results.

【 授权许可】

   
2014 Nie et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140722022308262.pdf 767KB PDF download
【 参考文献 】
  • [1]Baskin ML, Ard J, Franklin F, Allison DB: Prevalence of obesity in the United States. Obes Rev 2005, 6:5-7.
  • [2]Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, et al.: Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010, 363:2211-2219.
  • [3]Lavie CJ, Milani RV, Ventura HO: Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925-1932.
  • [4]Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF: Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007, 30:1562-1566.
  • [5]Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV: Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Failure 2013, 1:93-102.
  • [6]De Schutter A, Lavie CJ, Milani RV: The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease—the obesity paradox. Prog Cardiovasc Dis 2014, 56:401-408.
  • [7]Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR: Association of weight status with mortality in adults with incident diabetes. JAMA 2012, 308:581-590.
  • [8]Delgado-Rodríguez M, Medina-Cuadros M, Martínez-Gallego G, Sillero-Arenas M: Usefulness of intrinsic surgical wound infection risk indices as predictors of postoperative pneumonia risk. J Hosp Infect 1997, 35:269-276.
  • [9]Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW: A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000, 160:3082-3088.
  • [10]Newell MA, Bard MR, Goettler CE, Toschlog EA, Schenarts PJ, Sagraves SG, Holbert D, Pories WJ, Rotondo MF: Body mass index and outcomes in critically injured blunt trauma patients: weighing the impact. J Am Coll Surg 2007, 204:1056-1061.
  • [11]Yap CH, Zimmet A, Mohajeri M, Yii M: Effect of obesity on early morbidity and mortality following cardiac surgery. Heart Lung Circ 2007, 16:31-36.
  • [12]Dossett LA, Heffernan D, Lightfoot M, Collier B, Diaz JJ, Sawyer RG, May AK: Obesity and pulmonary complications in critically injured adults. Chest 2008, 134:974-980.
  • [13]Mannino DM, Davis KJ, Kiri VA: Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. Respir Med 2009, 103:224-229.
  • [14]Kornum JB, Nørgaard M, Dethlefsen C, Due KM, Thomsen RW, Tjønneland A, Sørensen HT, Overvad K: Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2010, 36:1330-1336.
  • [15]Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, Belay B, Jain S, Cox C, Kamimoto L, Fiore A, Finelli L, Olsen SJ, Fry AM: Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010, 5:e9694.
  • [16]Blumentals WA, Nevitt A, Peng MM, Toovey S: Body mass index and the incidence of influenza-associated pneumonia in a UK primary care cohort. Influenza Other Respir Viruses 2012, 6:28-36.
  • [17]Kwong JC, Campitelli MA, Rosella LC: Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011, 53:413-421.
  • [18]Viasus D, Paño-Pardo JR, Pachón J, Campins A, López-Medrano F, Villoslada A, Fariñas MC, Moreno A, Rodríguez-Baño J, Oteo JA, Martínez-Montauti J, Torre-Cisneros J, Segura F, Gudiol F, Carratalà J, Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI): Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 2011, 17:738-746.
  • [19]Phung D, Wang Z: Risk of pneumonia in relation to body mass index in Australian Aboriginal people. Epidemiol Infect 2013, 141:2497-2502.
  • [20]LaCroix AZ, Lipson S, Miles TP, White L: Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep 1989, 104:350-360.
  • [21]Salive ME, Satterfield S, Ostfeld AM, Wallace RB, Havlik RJ: Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults. Public Health Rep 1993, 108:314-322.
  • [22]Lange P, Vestbo J, Nyboe J: Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J 1995, 8:1694-1698.
  • [23]Inoue Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Tamakoshi A: Risk and protective factors related to mortality from pneumonia among middleaged and elderly community residents: the JACC study. J Epidemiol 2007, 17:194-202.
  • [24]Takata Y, Ansai T, Soh I, Akifusa S, Sonoki K, Fujisawa K, Awano S, Kagiyama S, Hamasaki T, Nakamichi I, Yoshida A, Takehara T: Association between body mass index and mortality in an 80-year-old population. J Am Geriatr Soc 2007, 55:913-917.
  • [25]Corrales-Medina VF, Valayam J, Serpa JA, Rueda AM, Musher DM: The obesity paradox in community-acquired bacterial pneumonia. Int J Infect Dis 2011, 15:e54-e57.
  • [26]King P, Mortensen EM, Bollinger M, Restrepo MI, Copeland LA, Pugh MJ, Nakashima B, Anzueto A, Hitchcock NP: Impact of obesity on outcomes for patients hospitalised with pneumonia. Eur Respir J 2013, 41:929-934.
  • [27]Kahlon S, Eurich DT, Padwal RS, Malhotra A, Minhas-Sandhu JK, Marrie TJ, Majumdar SR: Obesity and outcomes in patients hospitalized with pneumonia. Clin Microbiol Infect 2013, 19:709-716.
  • [28]Singanayagam A, Singanayagam A, Chalmers JD: Obesity is associated with improved survival in community-acquired pneumonia. Eur Respir J 2013, 42:180-187.
  • [29]Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
  • [30]Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp webcite. (9 February 2014, date last accessed)
  • [31]Greenland S, Longnecker MP: Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol 1992, 135:1301-1309.
  • [32]Orsini N, Greenland S: A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stata J 2011, 11:1-29.
  • [33]White IR: Multivariate random-effects meta-analysis. Stata J 2009, 9:40-56.
  • [34]Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D: Meta-analysis for linear and nonlinear dose–response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012, 175:66-73.
  • [35]Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM: Body-mass index and mortality in Korean men and women. N Engl J Med 2006, 355:779-787.
  • [36]Phung DT, Wang Z, Rutherford S, Huang C, Chu C: Body mass index and risk of pneumonia: a systematic review and meta-analysis. Obes Rev 2013, 14:839-857.
  • [37]Lagergren J: Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011, 8:340-347.
  • [38]Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A, Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group: New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J 2008, 31:1274-1284.
  • [39]Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT: Diabetes, glycemic control, and risk of hospitalization with pneumonia:a population-based case–control study. Diabetes Care 2008, 31:1541-1545.
  • [40]Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD, Dastani Z, Li R, Houston DK, Wood AR, Michaëlsson K, Vandenput L, Zgaga L, Yerges-Armstrong LM, McCarthy MI, Dupuis J, Kaakinen M, Kleber ME, Jameson K, Arden N, Raitakari O, Viikari J, Lohman KK, Ferrucci L, Melhus H, Ingelsson E, Byberg L, Lind L, Lorentzon M, et al.: Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013, 10:e1001383.
  • [41]Aregbesola A, Voutilainen S, Nurmi T, Virtanen JK, Ronkainen K, Tuomainen TP: Serum 25-hydroxyvitamin D3 and the risk of pneumonia in an ageing general population. J Epidemiol Community Health 2013, 67:533-536.
  • [42]Mancuso P: Obesity and respiratory infections: does excess adiposity weigh down host defense? Pulm Pharmacol Ther 2013, 26:412-419.
  • [43]Ozata M, Ozdemir IC, Licinio J: Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999, 84:3686-3695.
  • [44]Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW: Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010, 21:643-651.
  • [45]Goel K, Lopez-Jimenez F, De Schutter A, Coutinho T, Lavie CJ: Obesity paradox in different populations: evidence and controversies. Future Cardiol 2014, 10:81-91.
  • [46]Puren AJ, Feldman C, Savage N, Becker PJ, Smith C: Patterns of cytokine expression in community-acquired pneumonia. Chest 1995, 107:1342-1349.
  • [47]Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW: Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999, 277:E971-E975.
  • [48]van de Garde EM, Oosterheert JJ, Bonten M, Kaplan RC, Leufkens HG: International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol 2007, 60:834-838.
  文献评价指标  
  下载次数:50次 浏览次数:100次